Alternative Splicing in Breast Cancer and the Potential Development of Therapeutic Tools

Area of Science:

• Molecular Biology
• Oncology

Background:

• Alternative splicing is a crucial molecular mechanism in cancer development.
• Breast cancer, a leading cause of cancer deaths in women, involves alternative splicing, but its precise role is not fully understood.

Purpose of the Study:

• To provide a comprehensive overview of alternative splicing in breast cancer evolution.
• To analyze the prognostic and therapeutic implications of alternative splicing in breast cancer.
• To investigate the impact of alternative splicing on responses to endocrine and chemical therapies.

Main Methods:

• Literature review of recent findings on alternative splicing in breast cancer.
• Analysis of documented alternative splicing events and their association with disease progression.
• Examination of differential gene and isoform expression in relation to therapy response.

Main Results:

• Alternative splicing is a hallmark of breast cancer, contributing to its onset and progression.
• Specific alternative splicing events have prognostic and therapeutic value in breast cancer.
• Differential expression of splice variants affects patient response to established therapies.

Conclusions:

• Targeting alternative splicing presents an innovative therapeutic avenue for breast cancer.
• Understanding alternative splicing patterns can inform clinical decisions and improve patient outcomes.